Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,867,481
-$552,597 QoQ
Shares Held
46,442
+0.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#541
of 2,265 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOOMIS SAYLES & CO L P holds $1,754,958,212 across 10 Drug Manufacturers - General names. GILD ranks #7 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
18,594,352 | $891,413,233 | |
| 2 | NVS |
Novartis AG
|
5,239,309 | $821,104,505 | |
| 3 | ABBV |
AbbVie Inc.
|
43,544 | $10,957,411 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
170,634 | $9,831,930 | |
| 5 | MRK |
Merck & Co., Inc.
|
58,514 | $7,519,048 | |
| 6 | LLY |
ELI LILLY & Co
|
5,956 | $7,143,805 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
46,442 | $5,867,481 | |
| 8 | JNJ |
Johnson & Johnson
|
2,741 | $696,131 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,867,481 | 46,442 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,420,078 | 46,065 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $7,547,158 | 61,489 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $10,228,095 | 92,145 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,166,699 | 55,621 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $47,509 | 424 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $60,225 | 652 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $56,508 | 674 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $57,426 | 837 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $261,356 | 3,568 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $295,362 | 3,646 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $287,844 | 3,841 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $65,740 | 853 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $113,837 | 1,326 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $31,646 | 513 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $261,394 | 4,229 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $256,170 | 4,309 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $349,906 | 4,819 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $358,609 | 5,134 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $403,656 | 5,862 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,979,228 | 30,624 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $22,954 | 394 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,011,102 | 16,001 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $203,814 | 2,649 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $55,397 | 741 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||